AP NEWS
ADVERTISEMENT
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2020 Results ...

February 18, 2021 GMT

CAMBRIDGE, Mass., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Thursday, February 25, 2021, at 8:00 a.m. ET to discuss a corporate update and results for the fourth quarter and full year of 2020.

Conference Call & Webcast Details
Date: Thursday, February 25, 2021 
Time: 8:00 am Eastern Time
Toll Free: (844) 348-3801
International: (213) 358-0955
Conference ID: 7172199
Webcast: https://edge.media-server.com/mmc/p/hg6sbc5q

A live webcast of the conference call can be accessed in the Investors section of Editas Medicine website at  https://www.editasmedicine.com/.

ADVERTISEMENT


About Editas Medicine
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:
Media
Cristi Barnett
(617) 401-0113
cristi.barnett@editasmed.com

Investors
Editas Medicine Investor Relations
(617) 401-9052
ir@editasmed.com